Plasmodium falciparum resistance to piperaquine driven by PfCRT.
作者信息
Dhingra Satish K, Small-Saunders Jennifer L, Ménard Didier, Fidock David A
机构信息
Department of Microbiology and Immunology, Columbia University Irving Medical Center, New York 10032, NY, USA.
Division of Infectious Diseases in the Department of Medicine, Columbia University Irving Medical Center, New York 10032, NY, USA.
出版信息
Lancet Infect Dis. 2019 Nov;19(11):1168-1169. doi: 10.1016/S1473-3099(19)30543-2.
Abstract
摘要
相似文献
1
Plasmodium falciparum resistance to piperaquine driven by PfCRT.由恶性疟原虫氯喹抗性转运蛋白（PfCRT）驱动的恶性疟原虫对哌喹的抗性。
Lancet Infect Dis. 2019 Nov;19(11):1168-1169. doi: 10.1016/S1473-3099(19)30543-2.
2
Multigenic architecture of piperaquine resistance trait in Plasmodium falciparum.恶性疟原虫对哌喹耐药性状的多基因结构
Lancet Infect Dis. 2020 Jan;20(1):26-27. doi: 10.1016/S1473-3099(19)30689-9.
3
Emerging Southeast Asian PfCRT mutations confer Plasmodium falciparum resistance to the first-line antimalarial piperaquine.出现的东南亚 PfCRT 突变使恶性疟原虫对一线抗疟药哌喹产生耐药性。
Nat Commun. 2018 Aug 17;9(1):3314. doi: 10.1038/s41467-018-05652-0.
4
Susceptibility of Plasmodium falciparum to artemisinins and Plasmodium vivax to chloroquine in Phuoc Chien Commune, Ninh Thuan Province, south-central Vietnam.越南中南部宁顺省福川乡恶性疟原虫对青蒿素类药物的敏感性和间日疟原虫对氯喹的敏感性。
Malar J. 2019 Jan 17;18(1):10. doi: 10.1186/s12936-019-2640-2.
5
Combinatorial Genetic Modeling of pfcrt-Mediated Drug Resistance Evolution in Plasmodium falciparum.恶性疟原虫中pfcrt介导的耐药性进化的组合遗传建模
Mol Biol Evol. 2016 Jun;33(6):1554-70. doi: 10.1093/molbev/msw037. Epub 2016 Feb 22.
6
Polymorphisms of pfcrt, pfmdr1, and K13-propeller genes in imported falciparum malaria isolates from Africa in Guizhou province, China.贵州省从非洲输入的恶性疟原虫分离株中 pfcrt、pfmdr1 和 K13-推进器基因的多态性。
BMC Infect Dis. 2020 Jul 16;20(1):513. doi: 10.1186/s12879-020-05228-8.
7
[In vitro sensitivity of Plasmodium falciparum isolates from China-Myanmar border region to chloroquine, piperaquine and pyronaridine].[中国-缅甸边境地区恶性疟原虫分离株对氯喹、哌喹和咯萘啶的体外敏感性]
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2012 Feb 29;30(1):41-4.
8
Plasmodium falciparum Resistance to Artemisinin Derivatives and Piperaquine: A Major Challenge for Malaria Elimination in Cambodia.恶性疟原虫对青蒿素衍生物和哌喹的耐药性：柬埔寨疟疾消除面临的重大挑战。
Am J Trop Med Hyg. 2016 Dec 7;95(6):1228-1238. doi: 10.4269/ajtmh.16-0234. Epub 2016 Oct 17.
9
New genetic marker for piperaquine resistance in Plasmodium falciparum.恶性疟原虫对哌喹耐药性的新遗传标记
Lancet Infect Dis. 2017 Feb;17(2):119-121. doi: 10.1016/S1473-3099(16)30414-5. Epub 2016 Nov 3.
10
Accelerated evolution and spread of multidrug-resistant Plasmodium falciparum takes down the latest first-line antimalarial drug in southeast Asia.耐多药恶性疟原虫的加速进化与传播致使东南亚最新的一线抗疟药物失效。
Lancet Infect Dis. 2019 Sep;19(9):916-917. doi: 10.1016/S1473-3099(19)30394-9. Epub 2019 Jul 22.
引用本文的文献
1
The plasmepsin-piperaquine paradox persists in Plasmodium falciparum.恶性疟原虫中血浆蛋白酶-哌喹矛盾现象仍然存在。
PLoS Pathog. 2025 Jul 28;21(7):e1012779. doi: 10.1371/journal.ppat.1012779. eCollection 2025 Jul.
2
Plasmodiumfalciparum protein kinase 6 and hemozoin formation are inhibited by a type II human kinase inhibitor exhibiting antimalarial activity.一种具有抗疟活性的II型人激酶抑制剂可抑制恶性疟原虫蛋白激酶6和疟色素形成。
Cell Chem Biol. 2025 Jul 17;32(7):926-941.e23. doi: 10.1016/j.chembiol.2025.06.003. Epub 2025 Jul 7.
3
Slowing the spread of treatment failure to artemisinin-based combination therapies in Uganda.减缓乌干达基于青蒿素的联合疗法治疗失败的传播速度。
medRxiv. 2025 May 18:2025.05.15.25327701. doi: 10.1101/2025.05.15.25327701.
4
Decreased dihydroartemisinin-piperaquine protection against recurrent malaria associated with Plasmodium falciparum plasmepsin 3 copy number variation in Africa.在非洲，双氢青蒿素-哌喹对复发性疟疾的保护作用降低与恶性疟原虫天冬氨酸蛋白酶3拷贝数变异有关。
Nat Commun. 2025 Mar 18;16(1):2680. doi: 10.1038/s41467-025-57726-5.
5
Plasmodium falciparum African PfCRT Mutant Isoforms Conducive to Piperaquine Resistance Are Infrequent and Impart a Major Fitness Cost.导致对哌喹耐药的恶性疟原虫非洲PfCRT突变亚型并不常见，且会带来较大的适合度代价。
J Infect Dis. 2025 Jun 2;231(5):e976-e985. doi: 10.1093/infdis/jiae617.
6
A novel 4-aminoquinoline chemotype with multistage antimalarial activity and lack of cross-resistance with PfCRT and PfMDR1 mutants.一种新型 4-氨基喹啉类化合物，具有多阶段抗疟活性，与 PfCRT 和 PfMDR1 突变体无交叉耐药性。
PLoS Pathog. 2024 Oct 29;20(10):e1012627. doi: 10.1371/journal.ppat.1012627. eCollection 2024 Oct.
7
A genetic cross reveals the contributions of and to piperaquine drug resistance.一次基因杂交揭示了[相关基因]对哌喹耐药性的影响。 （注：原文中“and”前面应该缺失了一些内容，这里根据语境补充了“[相关基因]”，以便使译文更通顺，但严格按照要求，应按照你提供的原文准确翻译为：一次基因杂交揭示了和对哌喹耐药性的影响。不过这样的译文不太符合正常表达习惯。）
mBio. 2024 Jul 17;15(7):e0080524. doi: 10.1128/mbio.00805-24. Epub 2024 Jun 24.
8
Combating antimicrobial resistance in malaria, HIV and tuberculosis.抗疟疾、艾滋病毒和结核病中的抗菌药物耐药性
Nat Rev Drug Discov. 2024 Jun;23(6):461-479. doi: 10.1038/s41573-024-00933-4. Epub 2024 May 15.
9
Incomplete growth inhibition following piperaquine treatment translates into increased parasite viability in the parasite reduction ratio assay.哌喹治疗后不完全生长抑制导致寄生虫减少比率测定中寄生虫活力增加。
Front Cell Infect Microbiol. 2024 Apr 30;14:1396786. doi: 10.3389/fcimb.2024.1396786. eCollection 2024.
10
Assessing emergence risk of double-resistant and triple-resistant genotypes of Plasmodium falciparum.评估疟原虫双耐药和三耐药基因型的出现风险。
Nat Commun. 2024 Feb 15;15(1):1390. doi: 10.1038/s41467-024-45547-x.
本文引用的文献
1
Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological, and genetic study.中医疗法治疗失败的决定因素：柬埔寨、泰国和越南间日疟原虫疟疾的前瞻性临床、药理学和遗传学研究。
Lancet Infect Dis. 2019 Sep;19(9):952-961. doi: 10.1016/S1473-3099(19)30391-3. Epub 2019 Jul 22.
2
Evolution and expansion of multidrug-resistant malaria in southeast Asia: a genomic epidemiology study.东南亚耐多药疟疾的演变和扩散：一项基于基因组流行病学的研究。
Lancet Infect Dis. 2019 Sep;19(9):943-951. doi: 10.1016/S1473-3099(19)30392-5. Epub 2019 Jul 22.
3
Emerging Southeast Asian PfCRT mutations confer Plasmodium falciparum resistance to the first-line antimalarial piperaquine.出现的东南亚 PfCRT 突变使恶性疟原虫对一线抗疟药哌喹产生耐药性。
Nat Commun. 2018 Aug 17;9(1):3314. doi: 10.1038/s41467-018-05652-0.
4
A surrogate marker of piperaquine-resistant Plasmodium falciparum malaria: a phenotype-genotype association study.耐哌喹恶性疟原虫疟疾的替代标志物：一项表型-基因型关联研究。
Lancet Infect Dis. 2017 Feb;17(2):174-183. doi: 10.1016/S1473-3099(16)30415-7. Epub 2016 Nov 3.
5
Genetic markers associated with dihydroartemisinin-piperaquine failure in Plasmodium falciparum malaria in Cambodia: a genotype-phenotype association study.柬埔寨恶性疟原虫疟疾中与双氢青蒿素-哌喹治疗失败相关的遗传标记：一项基因型-表型关联研究。
Lancet Infect Dis. 2017 Feb;17(2):164-173. doi: 10.1016/S1473-3099(16)30409-1. Epub 2016 Nov 3.
Zotero 插件